Investigational Psychedelic for Adjustment Disorder in Cancer Patients
Led by Dr. David Feifel, MD, PhD, Kadima is San Diego's premier psychedelic research institute and a mental health clinic providing advanced, evidence-based treatments.
We are currently enrolling for a clinical trial that is investigating the effects of an investigational psychedelic compound on Adjustment Disorder in cancer patients.
This study is conducted under strict medical supervision and participation is completely legal.
You may qualify if you:
are 18-80 years old
Have been diagnosed with cancer recently
Have been experiencing unusually anxious, depressed, or overwhelming emotions
Can attend in-person visits at our La Jolla clinic
Enroll in just a few steps!
Complete a short eligibility survey
Complete a screening call with our study recruiter
If eligible and consenting, you will be enrolled in the study!
If you know someone struggling with emotions after a cancer diagnosis who may be interested in this opportunity, please share this with them.
David Feifel, MD, PhD
Professor Emeritus, UCSD · Founder, Kadima Neuropsychiatry
This study is done at Kadima Neuropsychiatry Institute in La Jolla, CA and is sponsored by Reunion Neuroscience.
A Randomized, Double-Blind, Parallel-Group, Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Adjustment Disorder in Patients With Cancer and Other Medical Illnesses.